Erin Davis, Senior Research Scientist at Melior Discovery

Erin Davis

Senior Research Scientist at Melior Discovery | Exton, Pennsylvania, United States

Profile last verified August 2026
Pharmaceuticals Verified Profile Exton, Pennsylvania, United States West Chester University of Pennsylvania
Verified

Personal Email

***@gmail.com

Personal • High Confidence

Phone Number

(215) ***-*420

United States • Phone

Free account · No credit card · 5 profiles/month

Erin Davis Socials
Erin Davis Work Experience

Senior Research Scientist at Melior Discovery in November 2014 - Present

Director of Laboratory Operations at Melior Discovery in March 2017 - Present

Senior Scientist at PPD in November 2012 - October 2014

See more See less

Research Scientist at Melior Discovery in October 2008 - November 2012

Study Technician at sanofi-aventis in June 2008 - October 2008

Assistant Scientist at GlaxoSmithKline in March 2006 - June 2008

Database Administrator at Creative Financial Group in November 2005 - March 2006

Assistant Girls Varsity Softball Coach at Downingtown West High School in March 2005 - June 2005

Erin Davis Education

West Chester University of Pennsylvania, January 2001 to January 2004

Ursinus College, January 2000 to January 2001

Erin Davis Skills
In Vivo Drug Discovery Pharmacology In Vitro ELISA Laboratory Automation Research R&D Life Sciences Pharmacokinetics Drug Metabolism DMPK High Throughput Screening GLP Microsoft Office Data Analysis Excel Metabolic Diseases ECL
About Erin Davis’s Current Company
Melior Discovery

Melior Discovery is a preclinical in vivo pharmacology contract research organization (CRO) headquartered in Exton, Pennsylvania. Founded in 2005, Melior specializes in in vivo phenotypic screening, drug repositioning (repurposing), and efficacy evaluation for global pharmaceutical and biotechnology companies. At the core of our capabilities is theraTRACE®, a proprietary high-throughput phenotypic screening platform utilizing multiplexed in vivo disease models. This unique platform allows drug discovery teams and developers to evaluate compounds across up to 40 distinct animal models of human disease simultaneously, spanning 14 therapeutic areas to uncover unexpected indications and de-risk pipeline decisions. Core Preclinical Services & Platforms: theraTRACE®: Multiplexed phenotypic screening for indications discovery. immuno-theraTRACE™: Oncology-focused screening for immune-modulating agents and tumor models. opioidTRACE®: Analgesic-focused platform evaluating pain pathways and abuse liability. Custom In Vivo Models: Over 150 validated rat and mouse models covering CNS, metabolic, inflammation, dermatology, and GI disorders. Supporting Services: Pharmacokinetic (PK) evaluations, bioanalytical services, and specialized surgery/implants (e.g., orthotopic intracranial). Since 2005, Melior has served hundreds of biopharma partners, from venture-backed startups to multinational pharmaceutical firms. Melior was recognized as CRO of the Year by Life Sciences Review and named a Top 20 CRO by Pharma Tech Outlook.

Discover more about Melior Discovery
Erin Davis’s Colleagues
Robert Bendesky

Robert Bendesky

Myrtle Beach, South Carolina, United States

Retired Research associate

Research Specialist at Perelman School of Medicine
(September 2026 – September 2026)

Kathryn Babiarz

Kathryn Babiarz

Wayne, Pennsylvania, United States

Client Coordinator at Melior Discovery

Graduate Research Assistant at University of Kentucky
(September 2026 – September 2026)

Kaitlyn Cappuccino

Kaitlyn Cappuccino

King of Prussia, Pennsylvania, United States

Research Associate at Melior Discovery

Surgical Core Research at PsychoGenics
(September 2026 – September 2026)

John Gruner

John Gruner

West Chester, Pennsylvania, United States

Director of Neurophysiology and Senior Scientific Fellow, Melior Discovery

Senior Scientist at Cephalon
(September 1992 – September 2026)

Joshua Taylor

Joshua Taylor

Pottstown, Pennsylvania, United States

Research Associate

Senior Assistant Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson
(September 2026 – September 2026)

Jonathan Palma

Jonathan Palma

Bensalem, Pennsylvania, United States

Director of Laboratory Management

Control Substance Officer at PsychoGenics
(September 2026 – September 2026)

Search similar profiles
Frequently asked questions about Erin Davis

What is Erin Davis email address?

Email Erin Davis at [email protected] and [email protected]. This email is the most updated Erin Davis's email found in 2026.

How to contact Erin Davis?

To contact Erin Davis send an email to [email protected] or [email protected].

What company does Erin Davis work for?

Erin Davis works for Melior Discovery.

What is Erin Davis's role at Melior Discovery?

Erin Davis is Senior Research Scientist

What industry does Erin Davis work in?

Erin Davis works in the Pharmaceuticals industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free